Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Oct 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4651749011 | Alpha/beta-arteether 75 mg/mL solution for injection | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4651750011 | Product containing precisely alpha/beta-arteether 75 milligram/1 milliliter conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely alpha/beta-arteether 75 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has manufactured dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely alpha/beta-arteether 75 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has precise active ingredient | Alpha/beta-arteether | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely alpha/beta-arteether 75 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has basis of strength substance | Alpha/beta-arteether | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely alpha/beta-arteether 75 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely alpha/beta-arteether 75 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely alpha/beta-arteether 75 milligram/1 milliliter conventional release solution for injection (clinical drug) | Plays role | Antimalarial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely alpha/beta-arteether 75 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | Product containing only alpha/beta-arteether in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR